Growth Metrics

Baxter International (BAX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Baxter International (BAX) over the last 17 years, with Q3 2025 value amounting to $111.0 million.

  • Baxter International's Capital Expenditures fell 1716.42% to $111.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $505.0 million, marking a year-over-year increase of 2438.42%. This contributed to the annual value of $446.0 million for FY2024, which is 324.07% up from last year.
  • As of Q3 2025, Baxter International's Capital Expenditures stood at $111.0 million, which was down 1716.42% from $140.0 million recorded in Q2 2025.
  • Over the past 5 years, Baxter International's Capital Expenditures peaked at $183.0 million during Q4 2021, and registered a low of -$61.0 million during Q4 2022.
  • Its 5-year average for Capital Expenditures is $122.1 million, with a median of $137.0 million in 2022.
  • Its Capital Expenditures has fluctuated over the past 5 years, first crashed by 13333.33% in 2022, then surged by 101666.67% in 2024.
  • Baxter International's Capital Expenditures (Quarter) stood at $183.0 million in 2021, then plummeted by 133.33% to -$61.0 million in 2022, then skyrocketed by 250.82% to $92.0 million in 2023, then surged by 43.48% to $132.0 million in 2024, then decreased by 15.91% to $111.0 million in 2025.
  • Its Capital Expenditures stands at $111.0 million for Q3 2025, versus $140.0 million for Q2 2025 and $122.0 million for Q1 2025.